Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer

Clinical trial NCT00288249 · COMPLETED

Trial details

NCT number: NCT00288249
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Breast Cancer, Metastatic

Start date: 2005-12-01
Primary completion: 2008-03-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.